Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait

被引:34
|
作者
Liu, C. [1 ]
Yang, W. [1 ]
Pei, D. [2 ]
Cheng, C. [2 ]
Smith, C. [1 ]
Landier, W. [3 ]
Hageman, L. [3 ]
Chen, Y. [3 ]
Yang, J. J. [1 ]
Crews, K. R. [1 ]
Kornegay, N. [1 ]
Karol, S. E. [4 ]
Wong, F. L. [5 ]
Jeha, S. [4 ]
Sandlund, J. T. [4 ]
Ribeiro, R. C. [4 ]
Rubnitz, J. E. [4 ]
Metzger, M. L. [4 ]
Pui, C-H [4 ]
Evans, W. E. [1 ]
Bhatia, S. [3 ]
Relling, M. V. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[4] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[5] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; CHILDRENS-ONCOLOGY-GROUP; DRUG-METABOLISM GENES; S-METHYLTRANSFERASE; MERCAPTOPURINE INTOLERANCE; CAUCASIAN POPULATION; BLACK SUBJECTS; CHILDHOOD; POLYMORPHISM;
D O I
10.1002/cpt.463
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We performed a genomewide association study (GWAS) of primary erythrocyte thiopurine S-methyltransferase (TPMT) activity in children with leukemia (n= 1,026). Adjusting for age and ancestry, TPMT was the only gene that reached genomewide significance (top hit rs1142345 or 719A> G; P= 8.6x 10(-61)). Additional genetic variants (in addition to the three single-nucleotide polymorphisms [SNPs], rs1800462, rs1800460, and rs1142345, defining TPMT clinical genotype) did not significantly improve classification accuracy for TPMT phenotype. Clinical mercaptopurine tolerability in 839 patients was related to TPMT clinical genotype (P= 2.4x 10(-11)). Using 177 lymphoblastoid cell lines (LCLs), there were 251 SNPs ranked higher than the top TPMT SNP (rs1142345; P= 6.8x 10(-5)), revealing a limitation of LCLs for pharmacogenomic discovery. In a GWAS, TPMT activity in patients behaves as a monogenic trait, further bolstering the utility of TPMT genetic testing in the clinic.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 50 条
  • [1] MERCAPTOPURINE PHARMACOGENETICS - MONOGENIC INHERITANCE OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY
    WEINSHILBOUM, RM
    SLADEK, SL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1980, 32 (05) : 651 - 662
  • [2] THIOPURINE METHYLTRANSFERASE - MONOGENIC INHERITANCE IN THE MOUSE
    OTTERNESS, DM
    WEINSHILBOUM, RM
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 443 - 443
  • [3] MOUSE THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - MONOGENIC INHERITANCE
    OTTERNESS, DM
    WEINSHILBOUM, RM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 240 (03): : 817 - 824
  • [4] Thiopurine Methyltransferase Pharmacogenomic Testing: Known But Infrequently Done
    Campbell, S. C.
    McMillin, G.
    Sherwin, C. M. T.
    Spigarelli, M. G.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 714 - 715
  • [5] Using HapMap tools in pharmacogenomic discovery: The thiopurine methyltransferase polymorphism
    Jones, T. S.
    Yang, W.
    Evans, W. E.
    Relling, M. V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 729 - 734
  • [6] Thiopurine methyltransferase activity and azathioprine
    Walmsley, TA
    Florkowski, CM
    George, PM
    Pike, LS
    NEW ZEALAND MEDICAL JOURNAL, 2002, 115 (1156) : 302 - 302
  • [7] Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase
    Khoa A. Nguyen
    Himalaya Patel
    David A. Haggstrom
    Alan J. Zillich
    Thomas F. Imperiale
    Alissa L. Russ
    BMC Medical Informatics and Decision Making, 19
  • [8] Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase
    Nguyen, Khoa A.
    Patel, Himalaya
    Haggstrom, David A.
    Zillich, Alan J.
    Imperiale, Thomas F.
    Russ, Alissa L.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2019, 19 (01)
  • [9] Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health system
    Root, Adam
    Johnson, Randall
    McGee, Ann
    Lee, Hui-Jie
    Yang, Siyun
    Voora, Deepak
    PHARMACOGENOMICS, 2020, 21 (06) : 411 - 418
  • [10] HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY
    WEINSHILBOUM, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 23 (01) : 134 - 134